Role of measuring blood supply of eye with other biophysical markers at 19-24 weeks in detecting development of high blood pressure in pregnancy
Not Applicable
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2021/10/037200
- Lead Sponsor
- Fernandez Hospital Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•All singleton mothers booked before 24 weeks
•Mothers who birth at Fernandez Hospital
•Singleton pregnancies with structurally normal fetus between 19-24 weeks
•Population who are unscreened for preeclampsia in first trimester
Exclusion Criteria
1.Pregnancies with aneuploidy and major fetal abnormality
2.Multifetal pregnancy
3.Miscarriage or fetal death before 26 weeks
3.Loss to follow up
4.Screened for pre-eclampsia in first trimester
5.Mothers with renal disease causing hypertension and proteinuria
6.Mothers with ocular/ ophthalmic artery pathologies using vasodilating drug
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To predict preterm PE (37 weeks) and term PE (â?¥37weeks) using Opthalmic artery doppler <br/ ><br> <br/ ><br>Timepoint: After delivery and discharge from the hospital. <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Preterm and term delivery and development of pre-eclampsia using Ophthalmic artery doppler, Uterine artery PI, mean arterial pressure.Timepoint: 1 year